| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.18 | 5e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.22 | 1e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.19 | 0.0005 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.002 |